Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis.

By A. Mitchell, D. Ferguson, John Gill, J. Paul, P. Symonds. The Lancet Oncology, 2013

701 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline (2016, positive): “6%, respectively, among the general cancer survivor population.(98) In a systematic review of observational studies, the prevalence of depression and anxiety specifically among breast cancer survivors was 22% (range, 13%56%) using the Center for Epidemiological Studies for Depression, 22% (range, 17”
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. (2014, background): “9%, respectively.(75) As is the case for persons without concurrent physical illness, depression and anxiety co-occur among patients with cancer.”
A systematic review of reviews on the prevalence of anxiety disorders in adult populations (2016, methodology): “…2013; Amerio et al. 2014; Haller et al. 2014; Molyneaux et al. 2014), and used mainly DSM or ICD criteria to ascertain diagnoses (Fajutrao et al. 2009; Hawton et al. 2013; Mitchell et al. 2013; Amerio et al. 2014; Goldner et al. 2014; Mckechnie and John 2014; Baxter et al. 2013; Swets et al. 2014).”
Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority (2019, background): “was more prevalent among cancer survivors, compared to healthy controls [30].”